By Federal law, all vaccine providers should provide patients with the appropriate Vaccine Information Statement (VIS) whenever a vaccine is given. ; This booklet contains guidelines for using Vaccine Information Statements, frequently asked questions, and camera-ready copies of all currently-available VIS's. By Federal law, all vaccine providers should provide patients with the appropriate Vaccine Information Statement (VIS) whenever a vaccine is given. ; This booklet contains guidelines for using Vaccine Information Statements, frequently asked questions, and camera-ready copies of all currently-available VIS's. Influenza (Live, Intranasal) Vaccine (VIS) Influenza Vaccine (Inactivated or Recombinant) (VIS) Meningococcal ACWY Vaccines (VIS) Meningococcal Disease: Information for Teens and College Students. MMR (Measles, Mumps, and Rubella) Vaccine (VIS) MMRV (Measles, Mumps, Rubella, and Varicella) Vaccine (VIS) Pneumococcal Conjugate Vaccine (VIS)
HealthMap Vaccine Finder is a free, online service where users can search for locations that offer immunizations. We work with partners such as clinics, pharmacies, and health departments to provide accurate and up-to-date information about vaccination services.
Vaccine Information Statements (VIS) are written to fulfill the information requirements of the National Childhood Vaccine Injury Act, and cover the benefits and risks associated with immunization, as well as adverse event management and informational resources. Check out our fact sheets below to learn how these vaccine-preventable diseases are spread, the risks to your health if you get sick with any of these diseases, as well as the vaccines that prevent them. INDICATION FOR PENTACEL AND QUADRACEL VACCINES. Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b. Pentacel vaccine is approved for use as a 4-dose series in children 6 weeks through 4 years of age (prior to fifth birthday). Influenza Vaccination Codes CVX (140) See Flu Cheat Sheet IPV CVX (10) IPOL Japanese Encephalitis-IM CVX (134) IXIARO MMR CVX (3) MMR II MMR/Varicella (MMRV) CVX (94) ProQuad Meningococcal ACWY (MCV4O) CVX (136) Menveo Meningococcal ACWY (MCV4P) CVX (114) Menactra Meningococcal B, OMV CVX (163) Bexsero Meningococcal B, Recombinant CVX (162 ...
NCIRS fact sheets, FAQs and other resources have been developed primarily for immunisation providers. However, these may also be of interest to members of the public. In Illinois, the five-year median (2002-2006) for meningococcal disease is approximately 46 cases a year. Fewer than 10 percent of all meningococcal disease cases are fatal. Death occurs more often in meningococcemia (as high as 17 percent) than in meningococcal meningitis (approximately 7 percent). How is meningococcal disease treated?
Vaccine Information Statement Update: Serogroup B Meningococcal (MenB) August 11, 2016—The Florida Department of Health, Immunization Section, would like to share the Centers for Disease Control and Prevention's (CDC) updated Vaccine Information Statement (VIS) for Serogroup B Meningococcal (MenB) released 8/9/2016. Serogroup B Meningococcal Vaccine (MenB) (VIS) (Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. meningococcal disease. Meningococcal infections can be treated with drugs such as penicillin. Still, about 1 out of every ten people who get the disease dies from it, and many others are affected for life. This is why preventing the disease through use of meningococcal vaccine is important for people at highest risk. 2 Meningococcal vaccine
Influenza (Live, Intranasal) Vaccine (VIS) Influenza Vaccine (Inactivated or Recombinant) (VIS) Meningococcal ACWY Vaccines (VIS) Meningococcal Disease: Information for Teens and College Students. MMR (Measles, Mumps, and Rubella) Vaccine (VIS) MMRV (Measles, Mumps, Rubella, and Varicella) Vaccine (VIS) Pneumococcal Conjugate Vaccine (VIS) protects against meningococcal disease caused by serogroups A, C, W and Y. This dose of MenACWY vaccine replaced the combined . Haemophilus influenza. type b–meningococcal C conjugate (Hib-MenC) vaccine (Menitorix ®) given at 12 months of age which only covered serogroup C. Meningococcal B VIS August 15, 2019 The "interim" VIS issued by CDC on 8/15/19 will be replaced by a "final" version in approximately 6 months, at which time IAC will provide translations in Spanish, Arabic, Burmese, Chinese (Simplified and Traditional), French, Russian, Somali, and Vietnamese.
The Hepatitis B VIS has received a minor update, noting that a 2-dose series is available. Stocks of the existing (7/20/16) edition may be used up before switching to this updated edition. Updated Vaccine Information Statements for Meningococcal ACWY Vaccine and DTaP Vaccine have been posted on ... Patient Handouts. For your convenience, Kendall Pediatric Partners of Miami, Florida offers resources to help you learn more about health concerns and conditions that may affect your child or adolescent.